How Your Thyroid Works - Controlling hormones essential to your metabolism
Jan 23, There is really only one option for treating hypothyroidism, and that is T3 and T4 are not equal in strength; T3 is the more active hormone of. Thyroxine is a hormone produced by the thyroid. It is drawn to assess thyroid function. Low T4 is seen with hypothyroidism. High T4 is seen with hyperthyroidism. Jun 1, The relationship between serum TSH and circulating thyroid hormones gives a . b Normal free T4 concentration (and free T3 for hyperthyroidism) Hence, the general advice that tests of thyroid function during pregnancy.
Written by Robert M. Sargis MD, PhD Your thyroid gland is a small gland, normally weighing less than one ounce, located in the front of the neck. It is made up of two halves, called lobes, that lie along the windpipe trachea and are joined together by a narrow band of thyroid tissue, known as the isthmus.
Thyroid Blood Tests
The thyroid is situated just below your "Adams apple" or larynx. During development inside the womb the thyroid gland originates in the back of the tongue, but it normally migrates to the front of the neck before birth.
Sometimes it fails to migrate properly and is located high in the neck or even in the back of the tongue lingual thyroid.Causes of normal T3,T4 levels but low TSH levels - Dr. Anantharaman Ramakrishnan
This is very rare. Thyroxine is a hormone produced by the thyroid. It is drawn to assess thyroid function. Low T4 is seen with hypothyroidism.
Understanding Your Hypothyroidism Test Results
High T4 is seen with hyperthyroidism. The T4 blood test can also be used to monitor the effectiveness of medications used to treat thyroid disease.
- Endotext [Internet].
- Treating Hypothyroidism
- Don't Miss Out! Get the FREE EndocrineWeb eNewsletter!
Estrogen, anticonvulsants, aspirin use and anticoagulants may affect T4 levels. They are increased with pregnancy. Thyroid antibodies are present if hypothyroid is related to thyroiditis. Hypothyroid can be caused by primary thyroid disease.
It also can be related to other health problems, such as glucocorticoid or amiodarone use, osteoporosis, pregnancy, insulin dependent diabetes and liver disease. Note the much higher prevalence of TSH abnormalities in the total population, than in the reference population.
For example, in Hong Kong, where iodine intake is marginally deficient, only 1.
Several European studies 62,63 have compared the effect of various levels of iodine intake on the prevalence of thyroid over- and under-function.
Hypothyroidism is generally more common with abundant iodine intake, while goitre and subclinical hyperthyroidism are more common with low iodine intake 62, These regional differences may influence the choice of diagnostic test and target population. For example, in an iodine replete environment, emphasis could be placed on testing younger or pregnant women for subclinical hypothyroidism by measurement of TSH and peroxidase antibody, whereas in an iodine-deficient region there might be additional emphasis on early detection of thyroid autonomy and hyperthyroidism in older people, using a highly sensitive TSH assay.
Clinical Strategies in the Testing of Thyroid Function - Endotext - NCBI Bookshelf
The term 'subclinical' is used when the serum concentration of TSH is persistently abnormal however definedwhile the concentrations of T4 and T3 remain within their reference intervals. Because results can fluctuate spontaneously, a new diagnosis of subclinical thyroid dysfunction is not warranted on the basis of a single laboratory sample.
The following five criteria define endogenous subclinical thyroid dysfunction: Apart from the situation of impending or early pregnancy, where there is clear consensus that subclinical hypothyroidism should be promptly and fully treated, the approach to subclinical thyroid dysfunction remains uncertain. Various authorities express divergent views on the importance of detecting the mild TSH abnormalities that reflect subclinical thyroid dysfunction. Extremes of opinion can be summarized as follows.
On the one hand, some take the position that subclinical thyroid dysfunction, both hypothyroidism and hyperthyroidism, are disorders that need to be treated in order to avert potential harm Active search for subclinical thyroid dysfunction is based on the view that treatment is usually justified, because of potential adverse outcome, even if proof of benefit is still lacking.
At this end of the opinion spectrum, there is support for general community screening for thyroid dysfunction 64in contrast to a case-finding strategy for women over 50 when they present for medical care 1. Others have taken the view that while there is circumstantial evidence that subclinical thyroid dysfunction can have adverse long-term effects, there is currently a lack of strong evidence that treatment confers benefit 66, A definitive position on this dilemma may emerge from long-term studies of outcome, but if differences are small, studies may be under-powered and the results may be indeterminate.
Other factors to be taken into account in establishing an approach to widespread thyroid testing include ethnic or environmental predisposition to thyroid dysfunction in various communities, balance with other healthcare priorities that may be more compelling, cost of laboratory testing and the extent to which competent clinical assessment and therapeutic response may be overwhelmed by reliance on laboratory measurements.
The special issues that need to be considered in establishing a strategy for the testing of thyroid function before, during and after pregnancy are considered in section 6. There is still conflicting evidence on whether mild thyroid abnormalities influence cardiovascular mortality and, as yet, no convincing support for the proposition that treatment of subclinical thyroid dysfunction improves survival.
In contrast, another survey of the relationship between serum TSH and all-cause and cardiovascular mortality over a 10 year period in individuals over 60, showed that the group with serum TSH below 0. More recent studies provide strengthening evidence for adverse effects from minor degrees of thyroid dysfunction. A Scottish study 72 of over 17, people followed for an average of 4. These findings appeared to be at odds with the initial evaluation of the Wickham data that showed no adverse cardiovascular effects of subclinical hypothyroidism.
However, reanalysis of the Whickham findings 73 did show an adverse effect if the beneficial effect of thyroxine treatment was excluded.
Table 2Reported effects of subclinical thyroid dysfunction Subclinical hyperthyroidism suppressed TSH, normal free T4, normal free T3 Exposure to iodine may precipitate severe thyrotoxicosis 74 Threefold increased risk of atrial fibrillation after 10 years 75 Abnormalities of cardiac function 76,77 Osteoporosis risk increased 78,79 Progression to overt hyperthyroidism 80,81 Subclinical hypothyroidism or mild thyroid failure increased TSH, normal free T4 Non-specific symptoms may improve with treatment 83 Progression to overt hypothyroidism 84 Independent risk factor for atherosclerosis?
Meyerovitch 82 reported the results of sequential tests of thyroid function over a 5-year period in a large community-based cohort. While some subjects did show progression, the high chance of resolution towards normal suggests that retesting after follow-up, possibly after at least 6 months, is advisable before considering any intervention. However, quantitative conclusions from that retrospective study may be insecure, as many subjects with abnormal TSH were excluded from follow-up because they were treated after their initial result If those treated were the more severely affected, whether based on symptoms, presence of goiter, or degree of TSH abnormality, the analysis may over-estimate the likelihood of resolution during follow-up.
However, it should be noted that the transition from immune subclinical to overt hyperthyroidism can occur more rapidly than is generally the case in immune hypothyroidism 98a. As yet, there is no study that shows that treatment given on the basis of low TSH alone, modifies this risk, although it is clear that survival is adversely affected by atrial fibrillation Impaired left ventricular ejection fraction and reduced exercise capacity has been documented in subclinical hyperthyroidism due to high dosage thyroxine and may be alleviated by beta blockade Prior knowledge of subnormal serum TSH may identify a high risk group with thyroid autonomy in whom iodine exposure carries the risk of iatrogenic hyperthyroidism.
Overt hyperthyroidism is associated with reduced bone density, predominantly affecting cortical rather than trabecular bone, so that the femoral neck is more affected than the lumbar spine, associated with an increase in fracture rate It has now been shown that women over 65 with suppressed TSH are at increased risk of hip and vertebral fractures Notably, in a controlled trial of suppressive T4 treatment for multinodular goitre, TSH suppression without clear excess of serum T4 or T3 resulted in a mean 3.
The study by Meyerovitch 82 showed that with the initial serum TSH in the range 5. Antibody status was not assessed in that cohort. Progression was not uniform, and over half of the cohort showed no deterioration of thyroid function, but positive microsomal antibodies increased the likelihood of progression. It is now clear that the opposite sequence may also occur, with spontaneous normalization of elevated TSH values 82, Notably, a recent prospective study has shown that the progression of immune subclinical hypothyroidism tends to be slower than for subclinical hyperthyroidism 98a.
Hence, the need for prolonged follow-up and patient education, where the decision to treat is deferred. Serum TSH appears to be the strongest of these predictors. This effect was independent of body mass index, total and HDL cholesterol, blood pressure and smoking status. The attributable risk for subclinical hypothyroidism was comparable to that for the other major risk factors, hypercholesterolemia, hypertension, smoking and diabetes mellitus. The association was slightly stronger when subclinical hypothyroidism was associated with positive peroxidase antibody, but thyroid autoimmunity itself was not an independent risk factor.
Thyroxine replacement for 18 months has been reported to improve blood pressure, lipids and carotid intimal thickness in women with subclinical hypothyroidism The difference could not be attributed to a difference in maximal nitrate-induced vasodilatation, age, sex, hypertension, diabetes, smoking, serum cholesterol, or levels of total T3 and T4 This finding suggests that even minor deviation from an individual's pituitary-thyroid set point may be associated with alteration in vasodilatory response.
There is no known direct action of TSH that would account for this effect. A Japanese placebo-controlled study of women aged with subclinical hypothyroidism with mean pre-treatment serum TSH of 7. These changes, which were associated with reduced cardiorespiratory work capacity during maximal exercise, were reversed by T4 treatment sufficient to normalize serum TSH Thyroxine treatment sufficient to normalise TSH to a mean of 1.
It remains to be established how these reversible abnormalities relate to cardiovascular prognosis.